These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9607035)

  • 1. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years.
    Fan PC; Chang MH; Lee PI; Safary A; Lee CY
    Vaccine; 1998; 16(2-3):232-5. PubMed ID: 9607035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.
    Castillo de Febres O; Chacon de Petrola M; Casanova de Escalona L; Naveda O; Naveda M; Estopinan M; Bordones G; Zambrano B; Garcia A; Dumas R
    Vaccine; 1999 Nov; 18(7-8):656-64. PubMed ID: 10547425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).
    Vidor E; Ratheau C; Briantais P; Vuillier D
    J Travel Med; 1998 Dec; 5(4):167-72. PubMed ID: 9876189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.
    Maiwald H; Jilg W; Bock HL; Löscher T; Sonnenburg F
    Vaccine; 1997 Mar; 15(4):346-8. PubMed ID: 9141202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
    Totos G; Gizaris V; Papaevangelou G
    Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
    Lagos R; Munoz A; Dumas R; Pichon S; Zambrano B; Levine M; Vidor E
    Vaccine; 2003 Sep; 21(25-26):3730-3. PubMed ID: 12922104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of an inactivated hepatitis A vaccine in healthy children: two years' follow-up.
    Lee WT; Chang MH; Lee CY; Chen DS; Safary A; Andre FE
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):331-5. PubMed ID: 8607357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1997 Jun; 52(2):215-8. PubMed ID: 9179771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.
    Yu C; Song Y; Qi Y; Li C; Jiang Z; Li C; Zhang W; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Oct; 12(10):2595-2602. PubMed ID: 27385349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
    Zanetti A; Pregliasco F; Andreassi A; Pozzi A; Viganò P; Cargnel A; Briantais P; Vidor E
    J Hepatol; 1997 Jan; 26(1):25-30. PubMed ID: 9148018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.